These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11164856)

  • 21. Lipolysis of emulsion models of triglyceride-rich lipoproteins is altered in male patients with abdominal aorta aneurysm.
    Hosni JJ; Vinagre CG; Mady C; Maranhão RC
    Braz J Med Biol Res; 2007 Mar; 40(3):305-7. PubMed ID: 17334526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of Serum Triglyceride Level and Gemfibrozil Consumption With Periodontal Status.
    Sayar F; Akhondi N; Fallah S; Moalemnia AA; Cheraghi A
    J Periodontol; 2017 May; 88(5):457-463. PubMed ID: 27958766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Features of cholesterol structure that regulate the clearance of chylomicron-like lipid emulsions.
    Mortimer BC; Tso P; Phan CT; Beveridge DJ; Wen J; Redgrave TG
    J Lipid Res; 1995 Sep; 36(9):2038-53. PubMed ID: 8558091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malignant hypertension is accompanied by marked alterations in chylomicron metabolism.
    Bernardes-Silva H; Toffoletto O; Bortolotto LA; Latrilha MC; Krieger EM; Pileggi F; Maranhão RC
    Hypertension; 1995 Dec; 26(6 Pt 2):1207-10. PubMed ID: 7498998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin action and glucose metabolism are improved by gemfibrozil treatment in hypertriglyceridemic patients.
    Avogaro A; Beltramello P; Marin R; Zambon S; Bonanome A; Biffanti S; Confortin L; Manzato E; Crepaldi G; Tiengo A
    Atherosclerosis; 1995 Feb; 113(1):117-24. PubMed ID: 7755647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The removal from plasma of chylomicrons and remnants is reduced in heterozygous familial hypercholesterolemia subjects with identified LDL receptor mutations: study with artificial emulsions.
    Carneiro MM; Miname MH; Gagliardi AC; Pereira C; Pereira AC; Krieger JE; Maranhão RC; Santos RD
    Atherosclerosis; 2012 Mar; 221(1):268-74. PubMed ID: 22257824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of anaesthesia on the removal from plasma of intravenously injected chylomicron-like lipid emulsions in rats and mice.
    Mortimer BC; Umeda Y; Elsegood CL; Redgrave TG
    Clin Exp Pharmacol Physiol; 1993 Jan; 20(1):51-8. PubMed ID: 8432040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chylomicron remnant metabolism in familial dyslipidemias studied with a remnant-like emulsion breath test.
    Redgrave TG; Watts GF; Martins IJ; Barrett PH; Mamo JC; Dimmitt SB; Marais AD
    J Lipid Res; 2001 May; 42(5):710-5. PubMed ID: 11352977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The diurnal rhythms of cholesterol metabolism and plasma clearance of model chylomicrons: comparison of normal and genetically hypercholesterolemic rats (RICO).
    Mortimer BC; Beveridge DJ; Phan CT; Lutton C; Redgrave TG
    Comp Biochem Physiol A Mol Integr Physiol; 1998 Aug; 120(4):671-80. PubMed ID: 9828396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationships in women between body mass index and the intravascular metabolism of chylomicron-like emulsions.
    Oliveira MR; Maranhão RC
    Int J Obes Relat Metab Disord; 2004 Nov; 28(11):1471-8. PubMed ID: 15486570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Opposite effects of bezafibrate and gemfibrozil in both normal and hypertriglyceridemic rats.
    Krause BR; Barnett BC; Essenburg AD; Kieft KA; Auerbach BJ; Bousley R; Stanfield R; Newton RS; Bisgaier CL
    Atherosclerosis; 1996 Nov; 127(1):91-101. PubMed ID: 9006809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized, double-blind study of gemfibrozil for the treatment of protease inhibitor-associated hypertriglyceridaemia.
    Miller J; Brown D; Amin J; Kent-Hughes J; Law M; Kaldor J; Cooper DA; Carr A
    AIDS; 2002 Nov; 16(16):2195-200. PubMed ID: 12409741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of gemfibrozil on insulin resistance to fat metabolism in subjects with type 2 diabetes and hypertriglyceridaemia.
    Whitelaw DC; Smith JM; Nattrass M
    Diabetes Obes Metab; 2002 May; 4(3):187-94. PubMed ID: 12047397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination of gemfibrozil and orlistat for treatment of combined hyperlipidemia with predominant hypertriglyceridemia.
    Tolentino MC; Ferenczi A; Ronen L; Poretsky L
    Endocr Pract; 2002; 8(3):208-12. PubMed ID: 12113634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postprandial lipoprotein metabolism in obese patients with moderate hypertriglyceridaemia: effects of gemfibrozil.
    Ditschuneit HH; Flechtner-Mors M; Hagel E; Ditschuneit H
    J Int Med Res; 1992 Jun; 20(3):197-210. PubMed ID: 1397665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clearance from plasma of triacylglycerol and cholesteryl ester after intravenous injection of chylomicron-like lipid emulsions in rats and man.
    Redgrave TG; Ly HL; Quintao EC; Ramberg CF; Boston RC
    Biochem J; 1993 Mar; 290 ( Pt 3)(Pt 3):843-7. PubMed ID: 8457213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma kinetics of chylomicron-like emulsion in renal transplant patients receiving cyclosporin-based immunosuppression.
    De Lima JJ; Latrilha Mda C; Toffoletto O; Ianhez LE; Krieger EM; Maranhão RC
    Clin Cardiol; 1998 Jun; 21(6):411-3. PubMed ID: 9631270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postprandial remnant-like lipoproteins in hypertriglyceridemia.
    Ooi TC; Cousins M; Ooi DS; Steiner G; Uffelman KD; Nakajima K; Simo IE
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3134-42. PubMed ID: 11443178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measurement of human chylomicron triglyceride clearance with a labeled commercial lipid emulsion.
    Park Y; Damron BD; Miles JM; Harris WS
    Lipids; 2001 Feb; 36(2):115-20. PubMed ID: 11269690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LDL concentration is correlated with the removal from the plasma of a chylomicron-like emulsion in subjects with coronary artery disease.
    Sposito AC; Santos RD; Hueb W; Ventura LI; Vinagre CC; Ramires JA; Maranhão RC
    Atherosclerosis; 2002 Apr; 161(2):447-53. PubMed ID: 11888530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.